On the afternoon of the 30th, during trading hours, HLB (028300) widened its losses and fell below the 30,000 KRW level. As volatility in the KOSDAQ market has increased recently, investor sentiment has contracted, drawing keen attention to the overall trend of group stocks led by HLB.

As of 1:12 p.m. on the 30th, HLB is trading at 29,700 KRW, down 1,550 KRW (-4.96%) from the previous trading day. With the intraday price dipping below the 30,000 KRW level, whether the stock can recover this support line has emerged as the top concern for investors.

Around the same time, other HLB group stocks also mostly showed a weak trend: • HLB Pharmaceutical: Down 6.27% at 7,920 KRW (largest decline within the group) • HLB Life Sciences: Down 4.40% at 1,931 KRW • HLB Innovation: Down 2.04% at 7,670 KRW • HLB Genex: Down 2.03% at 1,394 KRW • HLB Global: Down 0.68% at 1,162 KRW • Meanwhile, HLB Therapeutics: Up 1.71% at 1,546 KRW (the sole advancer within the group, standing out)

Market analysts note that biotech stocks, including HLB, are showing divergent patterns on a stock-by-stock basis depending on changes in investor sentiment, suggesting that short-term price movements should be closely monitored.

[Investment decisions are the responsibility of each individual, and as short-term volatility has expanded, a cautious approach is required.]